Home LiteratureArticle Details
PMID: 2807552 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Purification of Shiga toxin and Shiga-like toxins I and II by receptor analog affinity chromatography with immobilized P1 glycoprotein and production of cross-reactive monoclonal antibodies.

Infection and immunity ·Vol. 57 ·No. 12 ·1989-12-00 ·Pages 3888-93

Donohue-Rolfe A, Acheson DW, Kane AV, Keusch GT

Abstract

Shiga toxin from Shigella dysenteriae 60R was purified to homogeneity by a novel one-step receptor analog affinity chromatography method. The method was based on the binding affinity of Shiga toxin for a specific disaccharide, Gal alpha 1----4Gal, which was also present in glycoproteins with P1 blood group seroreactivity produced in hydatid cysts from sheep infected with Echinococcus granulosus. Having shown that cyst fluid P1 glycoprotein bound Shiga toxin on a solid phase, a P1 glycoprotein affinity column was made by coupling P1-active substance to Sepharose 4B. Shiga toxin was purified by this method in large quantities (5 to 10 mg/20-liter batch) with a consistently good yield (greater than 80% of starting toxin). Shiga-like toxins I and II (SLT-I and -II, respectively) from Escherichia coli were also purified by the same method. A preparation containing SLT-II and SLT-I purified by receptor analog affinity chromatography was used to raise four monoclonal antibodies (MAbs) that were reactive with SLT-II by enzyme-linked immunosorbent assay. Three of these antibodies also reacted with Shiga toxin, which was the first clear demonstration of cross-reactivity between these toxins. One MAb, 4D1, which was specific for the B subunit of SLT-II and Shiga toxin, neutralized both toxins in a HeLa cell cytotoxicity assay. Two MAbs recognized the A subunit of both SLT-II and Shiga toxin by Western blot (immunoblot) analysis but were unable to neutralize either toxin. In addition, one B-subunit-specific MAb neutralized SLT-II alone, and a previously described Shiga toxin B-subunit-specific MAb was shown to be specific for Shiga toxin but not SLT-II.

MeSH Terms
Animals Antibodies, Monoclonal/immunology Antibody Specificity Bacterial Toxins/immunology,isolation & purification,metabolism Blood Group Antigens/physiology Blotting, Western Chromatography, Affinity Cross Reactions Echinococcus/metabolism Molecular Weight P Blood-Group System/physiology Precipitin Tests Shiga Toxin 1 Shiga Toxin 2 Shiga Toxins
Chemicals
Antibodies, Monoclonal Bacterial Toxins Blood Group Antigens P Blood-Group System Shiga Toxin 1 Shiga Toxin 2 Shiga Toxins
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Donohue-Rolfe A
Department of Medicine, New England Medical Center, Boston, Massachusetts.
Acheson D W
Kane A V
Keusch G T
References (19)
19 references, click to expand
  1. The nature of the human blood group P1 determinant.
    Biochem Biophys Res Commun. 1974 Dec 23;61(4):1289-96 PMID: 4477014
  2. BLOOD GROUP P1 SUBSTANCE. I. CHEMICAL PROPERTIES.
    Bibl Haematol. 1964;19:225-9 PMID: 14267004
  3. Characterization of Shigella dysenteriae 1 (Shiga) toxin purified by anti-Shiga toxin affinity chromatography.
    Infect Immun. 1980 Oct;30(1):170-9 PMID: 7002787
  4. The P blood group system: recent progress in immunochemistry and genetics.
    Semin Hematol. 1981 Jan;18(1):63-71 PMID: 7010611
  5. Purification and biological characterization of shiga toxin from Shigella dysenteriae 1.
    Infect Immun. 1982 Jun;36(3):996-1005 PMID: 7047403
  6. Environmental and human isolates of Vibrio cholerae and Vibrio parahaemolyticus produce a Shigella dysenteriae 1 (Shiga)-like cytotoxin.
    Lancet. 1984 Jan 14;1(8368):77-8 PMID: 6140426
  7. Shiga-like toxin-converting phages from Escherichia coli strains that cause hemorrhagic colitis or infantile diarrhea.
    Science. 1984 Nov 9;226(4675):694-6 PMID: 6387911
  8. Pathogenesis of Shigella diarrhea. IX. Simplified high yield purification of Shigella toxin and characterization of subunit composition and function by the use of subunit-specific monoclonal and polyclonal antibodies.
    J Exp Med. 1984 Dec 1;160(6):1767-81 PMID: 6392471
  9. Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide.
    J Exp Med. 1986 Jun 1;163(6):1391-404 PMID: 3519828
  10. Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities.
    Infect Immun. 1986 Jul;53(1):135-40 PMID: 3522426
  11. Enzyme-linked immunosorbent assay for shigella toxin.
    J Clin Microbiol. 1986 Jul;24(1):65-8 PMID: 3522627
  12. Shiga and Shiga-like toxins.
    Microbiol Rev. 1987 Jun;51(2):206-20 PMID: 3299029
  13. Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins.
    Eur J Biochem. 1988 Jan 15;171(1-2):45-50 PMID: 3276522
  14. Cloning and sequencing of the genes for Shiga toxin from Shigella dysenteriae type 1.
    J Bacteriol. 1988 Mar;170(3):1116-22 PMID: 2830229
  15. Globotriosyl ceramide is specifically recognized by the Escherichia coli verocytotoxin 2.
    Biochem Biophys Res Commun. 1988 Apr 29;152(2):674-9 PMID: 3284526
  16. Affinity purification and characterization of Shiga-like toxin II and production of toxin-specific monoclonal antibodies.
    Infect Immun. 1988 Aug;56(8):1926-33 PMID: 3294179
  17. Isolation and characterization of monoclonal antibodies to Shiga-like toxin II of enterohemorrhagic Escherichia coli and use of the monoclonal antibodies in a colony enzyme-linked immunosorbent assay.
    J Clin Microbiol. 1988 Oct;26(10):2127-31 PMID: 3053764
  18. Shiga toxin: production and purification.
    Methods Enzymol. 1988;165:152-62, 399-401 PMID: 3231098
  19. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.
    Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350-4 PMID: 388439
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1989-12-00
Pages
3888-93
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC259922
Subset
IM
Grants
NIAID NIH HHS · AI-16242 · United States
NIAID NIH HHS · AI-20325 · United States
NIDDK NIH HHS · P30 DK-34928 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com